CN102784317B - Traditional Chinese medicine composition for treating aphtha - Google Patents
Traditional Chinese medicine composition for treating aphtha Download PDFInfo
- Publication number
- CN102784317B CN102784317B CN201210261002.7A CN201210261002A CN102784317B CN 102784317 B CN102784317 B CN 102784317B CN 201210261002 A CN201210261002 A CN 201210261002A CN 102784317 B CN102784317 B CN 102784317B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- aphtha
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating aphtha. The composition is prepared from the following Chinese herbal raw materials expressed in weight parts: 10 to 40 parts of milkvetch root, 10 to 30 parts of tangshen, 5 to 25 parts of bighead atractylodes rhizome, 5 to 25 parts of hyacinth bean, 5 to 25 parts of Chinese yam, 10 to 30 parts of rehmannia root, 5 to 20 parts of akebia stem, 5 to 20 parts of liquorice root, 5 to 25 parts of bamboo leaves and 3 to 10 parts of common rush. The traditional Chinese medicine composition provided by the invention has the effects of clearing heat, removing toxins, purging fire, promoting urination, nourishing yin, promoting fluid production, invigorating spleen-stomach, replenishing qi, tonifying lung, strengthening spleen, boosting essence and reinforcing kidney, exerts an remarkable and reliable curative effect on aphtha and has the advantages of wide sources of the compositional medicinal materials, simple preparation, moderate drug properties and no toxic and side effects.
Description
Technical field
The present invention relates to a kind of not medicinal preparation of definite structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of aphtha.
Background technology
Aphtha claims again oral ulcer, be a kind of oral mucosa limitation ulcerative lesions that outbreak is feature periodically repeatedly of take, can occur in the mucosa that lip, cheek, soft palate or the gums etc. in the ，Yi oral cavity, any position of oral mucosa locate common, there is single or a plurality of circular or oval ulcer differing in size, greyish white or the yellow pseudomembrane of surface coverage, concavity, clear border, around mucosa is red and micro-swollen, the local causalgia of ulcer is obvious, and severe patient also can affect appetite, and diet is caused to very big inconvenience.At present, the cause of disease of oral ulcer and mechanism of causing a disease are still indefinite.Modern medicine is thought, immunity, h and E may be " three factors " of oral ulcer morbidity, i.e. the immunoreation that genetic background and suitable environmental factors (comprising spiritual neural body constitution, psychological behavior state, life and work and social environment etc.) can exception throws and occur oral ulcer characteristic disease damage.Due to etiology unknown, the diagnosis of oral ulcer is based on medical history and clinical manifestation completely, lacks and can be used as the lab index of making a definite diagnosis foundation.Adopt clinically local antibacterial medicine (Chlorhexidine Acetate Gargles, chlortetracycline ointment etc.), topical corticosteroid (hydrogenation can have pine or fluorine light hydrogen prednisolone medicine film etc.), local analgesia agent (benzydamine gargarism or spray etc.), local anti-inflammatory preparation (aspirin gargarism, diclofenac etc.) to treat, exist the deficiency that falls flat, easily repeatedly shows effect.
The traditional Chinese medical science thinks, though the diseased region of aphtha in oral cavity, human body is all through all can be in mouth, The mouth is the body opening or window of the spleen, the tongue is the orifice to the heart, and the pharynx of the kidney pulse company is tongue basis, two cheeks and gums belong to stomach and large intestine, and conception vessel, governor vessel are all gone up network oral cavity words, show that the generation of aphtha and the five internal organs are in close relations.To be that feelings will is unsuccessful undermine heart spleen to its endogenous cause of ill, or hyperactivity of fire caused by deficiency of YIN, and pyretic toxicity is burnt bright, or in hold under the arm on damp and hot and attack Yu Kou; Exopathogenic factor comprises that stress is excessive, work fatigue, do not have enough sleep, dyspepsia, be hard and dry and also can bring out that this is sick or aggravate disease.
According to theory of Chinese medical science, for the pathogeny of aphtha, take QI invigorating in heat-clearing and toxic substances removing, pathogenic fire purging diuretic, benefit, tonifying the lung spleen invigorating is the rule for the treatment of, carries out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome prior art Chinese medicine and western medicine topical therapeutic aphtha, exist that effect is undesirable, the easy deficiency of outbreak repeatedly, the invention provides a kind ofly prepare conveniently, medicine source is wide, cost is low, evident in efficacy, reliable effect, a kind of Chinese medicine composition for the treatment of aphtha of having no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of aphtha, is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 10～40 parts of the Radixs Astragali, 10～30 parts of Radix Codonopsis, 5～25 parts of the Rhizoma Atractylodis Macrocephalaes, 5～25 parts of Semen Lablab Albums, 5～25 parts of Rhizoma Dioscoreaes, 10～30 parts, the Radix Rehmanniae, 5～20 parts of Caulis Akebiaes, 5～20 parts, Radix Glycyrrhizae, 5～25 parts, Folium Bambusae, 3～10 parts of Medulla Juncies.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of aphtha, is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 30 parts of the Radixs Astragali, 20 parts of Radix Codonopsis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Semen Lablab Albums, 15 parts of Rhizoma Dioscoreaes, 20 parts, the Radix Rehmanniae, 10 parts of Caulis Akebiaes, 10 parts, Radix Glycyrrhizae, 15 parts, Folium Bambusae, 5 parts of Medulla Juncies.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: the Radix Astragali has that benefiting QI for strengthening the superficies, tonifying the lung spleen invigorating, arresting sweating are admittedly de-, wind dispelling is transported malicious effect; Radix Codonopsis has the effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; The Rhizoma Atractylodis Macrocephalae has the effect of invigorating the spleen and benefiting QI, dampness diuretic; Semen Lablab Album has invigorating the spleen for eliminating dampness, and in the effect of relieving summer heat; Rhizoma Dioscoreae has strengthening the spleen and tonifying the lung, stomach reinforcing the kidney invigorating, the benefit of reinforcing the kidney essence, hearing-improing and eyesight improving, help the five internal organs, bone and muscle strengthening, grow that will is calmed the nerves, the effect of life lengthening; The Radix Rehmanniae has the effect of clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, pain relieving regulating menstruation; Caulis Akebiae has the effect of pathogenic fire purging row water, promoting blood circulation, the stimulating milk secretion of stimulating the menstrual flow; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription; Folium Bambusae has clearing heat and relieving fidgetness, the effect of the diuresis of promoting the production of body fluid; Medulla Junci has the effect of relieving stranguria by diuresis, clearing heart fire.Drug component in the present composition is through dialectical compatibility, complements each other using, and has synergism, plays altogether the effect of heat-clearing and toxic substances removing, pathogenic fire purging diuretic, YIN nourishing and the production of body fluid promoting, invigorating the spleen and replenishing QI, spleen benefiting and strengthen kidney, thereby reaches the object for the treatment of aphtha.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 93.7%, and cure rate reaches 50%.
The specific embodiment
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for aphtha, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 30g, Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 15g, Semen Lablab Album 15g, Rhizoma Dioscoreae 15g, Radix Rehmanniae 20g, Caulis Akebiae 10g, Radix Glycyrrhizae 10g, Folium Bambusae 15g, Medulla Junci 5g.
Embodiment 2
Treat a Chinese medicine composition for aphtha, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 40g, Radix Codonopsis 15g, Rhizoma Atractylodis Macrocephalae 10g, Semen Lablab Album 20g, Rhizoma Dioscoreae 5g, Radix Rehmanniae 10g, Caulis Akebiae 15g, Radix Glycyrrhizae 15g, Folium Bambusae 5g, Medulla Junci 10g.
Embodiment 3
Treat a Chinese medicine composition for aphtha, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 20g, Radix Codonopsis 30g, Rhizoma Atractylodis Macrocephalae 20g, Semen Lablab Album 5g, Rhizoma Dioscoreae 25g, Radix Rehmanniae 15g, Caulis Akebiae 5g, Radix Glycyrrhizae 20g, Folium Bambusae 10g, Medulla Junci 10g.
Embodiment 4
Treat a Chinese medicine composition for aphtha, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 25g, Radix Codonopsis 10g, Rhizoma Atractylodis Macrocephalae 25g, Semen Lablab Album 10g, Rhizoma Dioscoreae 20g, Radix Rehmanniae 25g, Caulis Akebiae 20g, Radix Glycyrrhizae 5g, Folium Bambusae 20g, Medulla Junci 3g.
Embodiment 5
Treat a Chinese medicine composition for aphtha, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 10g, Radix Codonopsis 25g, Rhizoma Atractylodis Macrocephalae 5g, Semen Lablab Album 25g, Rhizoma Dioscoreae 10g, Radix Rehmanniae 30g, Caulis Akebiae 10g, Radix Glycyrrhizae 10g, Folium Bambusae 25g, Medulla Junci 8g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soak 20～30 minutes, then add water and do not have approximately 8 centimetres of powder, decoct.At a simmer, adopt intense fire to decoct, after boiling, use slow fire boiling 20～30 minutes; Second decocts, and after water boils, decocts 15～20 minutes.Twice decoction extracting juice that removes slag, merges.
Treat a Chinese medicine composition for aphtha, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 64 examples, 15～65 years old age.
Two, usage and dosage: during clinical practice, the component in Chinese medicine composition, consumption are taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Potion on the one, the about 300ml of twice extracting juice of decocting, minute morning, evening take for twice.Period in a medicine is avoided pungent, plump product.
Three, criterion of therapeutical effect:
Recovery from illness: clinical symptoms and sign disappear, and follow up a case by regular visits to more than 6 months, and aphtha is recidivist not;
Effective: aphtha pain is aobvious to be subtracted, and rule of onset before breaking, the gap phase extends 6 months with interior not recurrence;
Take a turn for the better: aphtha pain takes a turn for the better to some extent, outbreak gap slightly extends before, and between stage of attack, part and General Symptoms are also improved;
Invalid: aphtha number, form and pain before and after treatment, outbreak gap phase and General Symptoms are all not improved.
Four, therapeutic effect: in this clinical observation case, the 5-30 days that takes medicine, 32 examples of fully recovering, effective 16,12 examples that take a turn for the better, invalid 4 examples.During treatment, there is not toxic and side effects.
Five, model case:
Case 1:
Grandson, female, 45 years old.Suffer from aphtha existing 2 years, never carry out regular treatment.Oral ulcer is shown effect repeatedly, and ulcer place is difficult for closing up.When medical, seeing its both sides, oral cavity has the ulcer differing in size several, and color and luster is light red to turn white, and hurt like hell hinders diet.And its complexion white, Mental fatigue is breathed hard, the timid cold fear of cold of extremity, large loose stool is thin, halitosis xerostomia, little yellow urine is red.Thick fur is greasy, and pale and tender tongue is and fat, and there is indentation on limit, deep-slow pulse.Take medicament 5 days prepared by Chinese medicine composition of the present invention, aphtha closes up gradually, and pain is slight, can normal diet, and General Symptoms is also improved; Continue and take 10 days, all disease knowing are removed; For consolidating curative effect, continue and take 5 days, aphtha not recurrence in 1 year.
Case 2:
Lee, female, 18 years old, student.Learning pressure is large, suffers from aphtha two months, tongue body and pharyngeally repeatedly fester, and hurt like hell, cannot swallow food, has had a strong impact on studying and living, once with antiinflammatory, pain relieving Western medicine, also has no improvement.Take medicament prepared by Chinese medicine composition of the present invention after 2 days. pain relief, can swallow on a small quantity food, continue to take ulcer all healed after 5 days, diet is normal, recovery from illness.
Claims (1)
1. a Chinese medicine composition for the treatment of aphtha, is characterized in that: its raw material of Chinese medicine forms and weight proportion is: Radix Astragali 30g, Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 15g, Semen Lablab Album 15g, Rhizoma Dioscoreae 15g, Radix Rehmanniae 20g, Caulis Akebiae 10g, Radix Glycyrrhizae 10g, Folium Bambusae 15g, Medulla Junci 5g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210261002.7A CN102784317B (en) | 2012-07-26 | 2012-07-26 | Traditional Chinese medicine composition for treating aphtha |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210261002.7A CN102784317B (en) | 2012-07-26 | 2012-07-26 | Traditional Chinese medicine composition for treating aphtha |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102784317A CN102784317A (en) | 2012-11-21 |
| CN102784317B true CN102784317B (en) | 2014-02-12 |
Family
ID=47150034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210261002.7A Expired - Fee Related CN102784317B (en) | 2012-07-26 | 2012-07-26 | Traditional Chinese medicine composition for treating aphtha |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102784317B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491840B (en) * | 2014-12-30 | 2016-08-31 | 中国人民解放军第四军医大学 | The mouth cavity medicine compositions of a kind of radioprotective preventing decayed tooth antiinflammatory and preparation thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1969959A (en) * | 2006-12-06 | 2007-05-30 | 洪之伦 | Externally applied medicament for treating bone fracture |
| CN101167900A (en) * | 2007-09-20 | 2008-04-30 | 吴月 | Traditional Chinese medicine for treating recurrent aphthae |
| CN101167980A (en) * | 2007-10-28 | 2008-04-30 | 刘新萍 | Traditional Chinese medicinal composition for treating infantile aphtha |
| CN101732521A (en) * | 2008-11-27 | 2010-06-16 | 冯有国 | Medicinal composition for treating fracture and preparation method thereof |
| CN102225109A (en) * | 2011-05-31 | 2011-10-26 | 汪庆 | Quick-acting fracture setting medicine powder |
-
2012
- 2012-07-26 CN CN201210261002.7A patent/CN102784317B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1969959A (en) * | 2006-12-06 | 2007-05-30 | 洪之伦 | Externally applied medicament for treating bone fracture |
| CN101167900A (en) * | 2007-09-20 | 2008-04-30 | 吴月 | Traditional Chinese medicine for treating recurrent aphthae |
| CN101167980A (en) * | 2007-10-28 | 2008-04-30 | 刘新萍 | Traditional Chinese medicinal composition for treating infantile aphtha |
| CN101732521A (en) * | 2008-11-27 | 2010-06-16 | 冯有国 | Medicinal composition for treating fracture and preparation method thereof |
| CN102225109A (en) * | 2011-05-31 | 2011-10-26 | 汪庆 | Quick-acting fracture setting medicine powder |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102784317A (en) | 2012-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550729B (en) | A kind of Chinese medicine composition for the treatment of cough | |
| CN102949630A (en) | Traditional Chinese medicine composition for treating abdominal distension caused by lack of gastrointestinal motility | |
| CN103272143B (en) | Traditional Chinese medicine composition for treating acne | |
| CN100364594C (en) | Medicine for treating chronic superficial gastritis and peptic ulcer diseases | |
| CN101757336A (en) | Formula of traditional Chinese medicine for treating chronic gastritis | |
| CN102988735A (en) | Chinese medicament composition for treating cough | |
| CN103211990B (en) | Chinese medicinal composition for treating oral ulcer | |
| CN102512552B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN102430105B (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
| CN101138613A (en) | Traditional Chinese medicine for treating acute bronchitis of children | |
| CN102949685A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN102784317B (en) | Traditional Chinese medicine composition for treating aphtha | |
| CN104667249B (en) | A kind of Chinese medicine composition for treating primary dysmenorrhea | |
| CN103463604A (en) | Drug for treating cough and asthma | |
| CN103006980A (en) | Chinese medicinal composition for treating distention and fullness | |
| CN103212027B (en) | Traditional Chinese medicine preparation for treating urinary calculus | |
| CN102872417B (en) | Traditional Chinese medicine nourishing zhong blood-activating decoction for treating chronic atrophic gastritis | |
| CN102302729B (en) | Chinese medicinal preparation for treating oral aphthae during menstruation | |
| CN104667026A (en) | Traditional Chinese medicine composition for treating gastrointestinal heat accumulation type constipation | |
| CN104784650A (en) | Pharmaceutical preparation for clinical nursing of gastric ulcer | |
| CN104001070A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN103877390A (en) | Traditional-Chinese-medicine preparation for treating rheumatic fever and preparation method thereof | |
| CN103877384A (en) | Traditional Chinese medicine preparation for treating rectal cancer and preparation method thereof | |
| CN104013708A (en) | Traditional Chinese medicine composition for oral administration to treat irritable bowel syndrome | |
| CN109316594B (en) | Decoction of Ershu dendrobe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140212 Termination date: 20140726 |
|
| EXPY | Termination of patent right or utility model |